University of South China — Hengyang, Hunan

Public research footprint of University of South China, compiled from the ClinicalTrials.gov public registry.

101

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Heart Failure · Non-small Cell Lung Cancer · Type 2 Diabetes Mellitus (T2DM) · Irritable Bowel Syndrome

Recently updated registry entries

NCT06736574 — Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely… (Recruiting)
NCT07454967 — Development of a Multimodal AI System for GIST Management (Completed)
NCT07361302 — A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at University of South China?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.